Navigation Links
Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings

750 patients in a double-blind, placebo-controlled, crossover safety study comparing a single dose of 510 mg ferumoxytol to placebo.

The company plans to issue a press release summarizing the data to be presented at the NKF meetings after market close on Wednesday, April 11, 2007. The announcement will be followed by a conference call at 4:30 pm ET to discuss and answer questions regarding the data from the completed studies and the status of the ferumoxytol development program.

To listen to this conference call via audio web cast, please visit the Investors section of the Advanced Magnetics website at www.advancedmagnetics.com. The web cast will also be available as a replay starting approximately one hour after the call is finished through July 11, 2007. Alternatively, to access the call via live telephone, please dial (800) 810-0924. Internationally, the call may be accessed by dialing (913) 981- 4900.

In addition to the web cast replay, a telephone replay will be available from approximately 7:30 p.m. ET on April 11, 2007 through April 25, 2007. To access the replay, please call (888) 203-1112 and use the pass code 2603141. The replay will also be available internationally at (719) 457-0820 using the same pass code.

About Advanced Magnetics

Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide nanoparticles used in pharmaceutical products. As a leader in our field, we are dedicated to the development and commercialization of our proprietary nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. For more information about us, please visit our website at http://www.advancedmagnetics.com, the content of which is not part of this press release.

This press release
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

Post Your Comments:
(Date:11/6/2009)... Oxygen Biotherapeutics, ...at a previously approved reverse split of its comm...on Monday, Nov. 9, 2009 on a 1-for-15 split-adjust... trade under the new symbol OXBT. The stock also w... split becomes effective. ,, "This reverse spli...
(Date:11/6/2009).... 6 Watson Pharmaceutica...ceutical company, announced today that Paul Bisaro...will provide an overview and update of the Company...hcare Conference on Wednesday, November 11, 2009 a...ntation will be webcast live and can be accessed o...
(Date:11/6/2009)...ov. 6 The ,Help is Here...ina and Georgia throughout the week of November 9-...d financially-struggling patients access informati... for free or nearly free. With the nation,s unempl...hip for Prescription Assistance (PPA) bus tour is ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3NYCs Only Walk in Botox Clinic SmoothMED Where Boytox Hits Men Right in the Brow 21 54529 1Edifecs Launches the Edifecs5010 28TM 29 Compliance Suite of Tools Resources and Services for 5010 Migration 54526 1Edifecs Launches the Edifecs5010 28TM 29 Compliance Suite of Tools Resources and Services for 5010 Migration 54526 2Edifecs Launches the Edifecs5010 28TM 29 Compliance Suite of Tools Resources and Services for 5010 Migration 54526 3Elpac Power System Extends Energy Star Portfolio with 65 Watt External Power Supply 54525 1Elpac Power System Extends Energy Star Portfolio with 65 Watt External Power Supply 54525 2
...s Overall Survival by 33% 3.5 Years Post Surgery, ...- CEL-SCI,CORPORATION announced today that its can...ncrease long term overall survival in a,Phase II s...re,presented on May 20, 2007 at the First Internat... Oral Oncology in Amsterdam, the,Netherlands, by D...
...INESS WIRE)--May 21, 2007 - Cougar Biotechnology,...ase I and Phase,II data on the Company,s prostate ... was presented at the American Urological,Associat...g place,in Anaheim, California. The data was prese...h UK Centre for Cancer Therapeutics at,The Institu...
Other Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4
(Date:11/8/2009)...biopharmaceuticals to be available at the Company&... Toronto, ON (PRWEB) November 8, 2...ure Biopharma Inc. today announced that the Compan...eutical grade freeze dryer and expects to make com...able for contract manufacturing of biopharmaceutic...
(Date:11/8/2009)...e in the Western District of Pennsylvania award a ...ing for a medical malpractice case. Attorneys Tho...omas E. Crenney and Associates, LLC handled the ca...d against the Uniontown Hospital. The woman had t...t age 18. , Pittsburgh, P...
(Date:11/8/2009)...e is won," said Dr. Charmaine Yoest. ,, WASHIN...of 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahl...on mandates and funding in HR 3962 passed on the H... President and CEO Dr. Charmaine Yoest said, "The ...-life Americans across this country who have flood...
(Date:11/8/2009)...wire/ -- USAction this evening hailed passage of t...ill make health care more affordable for consumers...e access to health care for millions of Americans ...DR and Harry Truman would be proud," said USAction...s among our country,s proudest achievements. Today...
(Date:11/8/2009)... to Secure the Stability of Medicare ,, HOUSTO...ributable to: J. James Rohack, M.D., President, Am...www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ...th reform bill, which will help improve the health...swift passage of H.R. 3961 to secure the stability...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... failure patients in United States have better sho... lose that advantage over time.// Their study...ves of Internal Medicine. Heart failure is th...ne-year risk-standardized mortality rates among 28...
... office atmosphere by reducing the workload and pr...Numerous studies have already demonstrated // the ...front of the computers. A new study now reveal...led dry eye. Dry eye is an irritating, painful con...
...te (QBI) have now found a process that could lead...suffering from dementia and acquired brain injury....part of the brain commonly associated with memory ...fessor Perry Bartlett, from The University of Quee...
... over the alarming increase of spread of HIV infec...aid that Indonesia has to face the AIDS effectivel...ead of HIV in Asis has become very high as one in ...of the spread of the communicable disease AIDS is ...
...dia’s Health Minister Anbumani Ramadoss on 29 Nove... made towards achieving the Millennium Development...ed to make recommendations and suggestions, and la...ef Yogi Deveshwar, and the head of the lobby's nat...
...gists has revealed that the libido of a patient ma...ing epilepsy.// The secretion and creation of test...ble of reducing the sexual drive of the patient. ... no drugs help, which is the case for about one-qu...
Other Medicine News:Health News:Disparity In Survival Rates In US and Canadian heart Patients 2Health News:Not Blinking Enough In Front Of The Computer Can Cause Dry Eye 2Health News:Research Targets treatment for dementia and brain injuries 2
Hardy Pituitary Spoons
Sundt AVM Micro Clip System
...t system. Material that has a modulus of elasticit...is an implant that meets the structural requiremen...e fusion environment through an open, load sharing...d 10 degrees of lordosis. Minimal instruments are ...
...anterior column support for single or multilevel c.... The system consists of one or more Peek Carbon F...eight, accommodating various patient needs. The Pe...es the biomechanical properties of human cortical ...
Medicine Products: